ADRIENNE TERRY: Open Payments
NPI 1134648520 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 45 payments from 20 companies in 2025. Trend: 2023 $1,201 · 2024 $11,678 · 2025 $1,006
Food & beverage: $856Speaker / faculty: $150
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $178 |
| Amgen Inc. | 9 | $147 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $78 |
| CeQur Corporation | 1 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Ascendis Pharma Endocrinology Inc | 3 | $52 |
| Chiesi USA, Inc. | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
Products named: REPATHA, CRENESSITY, TZIELD, EVENITY, CeQur Simplicity, LEQVIO, Yorvipath, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across UT — which companies pay providers there.
